A big breakthrough has come for India's Covaxin. The US Institute of Health has now highlighted the efficacy of Bharat Biotech's Covaxin against the Alpha and Delta variants of the Coronavirus. Two studies were conducted by US Health Institute and have stated that "India's Covaxin by Bharat Biotech in collaboration with the Indian Council Medical Research, effectively neutralizes both Alpha and Delta Variants of Coronavirus." The news of two different studies is certainly very encouraging for India. Times Now's Sherine reports that it is a huge endorsement for Bharat Biotech, which has now submitted its phase three trial data as well. Watch to know more.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting